These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20699624)

  • 61. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
    Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma.
    Naito S; Tsukamoto T; Usami M; Fujimoto H; Akaza H
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1065-70. PubMed ID: 20157711
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical outcome of oral uracil/tegafur (UFT) therapy for patients with hormone refractory prostate cancer.
    Miyake H; Hara I; Yamazaki H; Eto H
    Oncol Rep; 2005 Sep; 14(3):673-6. PubMed ID: 16077973
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases.
    Koutsilieris M; Mitsiades CS; Bogdanos J; Dimopoulos T; Karamanolakis D; Milathianakis C; Tsintavis A
    Clin Cancer Res; 2004 Jul; 10(13):4398-405. PubMed ID: 15240528
    [TBL] [Abstract][Full Text] [Related]  

  • 65. S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study.
    Furuse J; Okusaka T; Boku N; Ohkawa S; Sawaki A; Masumoto T; Funakoshi A
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):849-55. PubMed ID: 18214482
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy of S-1 in patients with castration-resistant prostate cancer: a phase II study.
    Akaza H; Ikemoto I; Namiki M; Usami M; Kobayashi M; Fujimoto H; Tsukamoto T; Naito S
    Oncology; 2010; 78(5-6):323-8. PubMed ID: 20699624
    [TBL] [Abstract][Full Text] [Related]  

  • 67.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 68.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.